AU547195B2 - Enhancers of anti-tumor effect - Google Patents

Enhancers of anti-tumor effect

Info

Publication number
AU547195B2
AU547195B2 AU73677/81A AU7367781A AU547195B2 AU 547195 B2 AU547195 B2 AU 547195B2 AU 73677/81 A AU73677/81 A AU 73677/81A AU 7367781 A AU7367781 A AU 7367781A AU 547195 B2 AU547195 B2 AU 547195B2
Authority
AU
Australia
Prior art keywords
tumor
enhancer
irradiation
animal
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU73677/81A
Other languages
English (en)
Other versions
AU7367781A (en
Inventor
Shigekazu Nakatsugawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Publication of AU7367781A publication Critical patent/AU7367781A/en
Application granted granted Critical
Publication of AU547195B2 publication Critical patent/AU547195B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU73677/81A 1980-08-11 1981-08-04 Enhancers of anti-tumor effect Ceased AU547195B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10932080A JPS5735516A (en) 1980-08-11 1980-08-11 Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
JP55-109320 1980-08-11

Publications (2)

Publication Number Publication Date
AU7367781A AU7367781A (en) 1982-02-18
AU547195B2 true AU547195B2 (en) 1985-10-10

Family

ID=14507226

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73677/81A Ceased AU547195B2 (en) 1980-08-11 1981-08-04 Enhancers of anti-tumor effect

Country Status (6)

Country Link
US (1) US4434788A (enExample)
EP (1) EP0045944B1 (enExample)
JP (1) JPS5735516A (enExample)
AU (1) AU547195B2 (enExample)
CA (1) CA1176168A (enExample)
DE (1) DE3160820D1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU578625B2 (en) * 1983-10-17 1988-11-03 Isis Pharmaceuticals, Inc. Method for inhibiting propagation of virus and anti-viral agent

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
DE3323621A1 (de) * 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
US4894364A (en) * 1983-10-26 1990-01-16 Greer Sheldon B Method and materials for sensitizing neoplastic tissue to radiation
US4815446A (en) * 1985-05-09 1989-03-28 Alpha Therapeutic Corporation Process for treating metastasis of cancerous tumors
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
USH669H (en) 1986-12-08 1989-09-05 The United States Of America As Represented By The United States Department Of Energy Samarium-145 and its use as a radiation source
JPH0365419A (ja) * 1989-08-03 1991-03-20 Mitsubishi Motors Corp 車両用サスペンション制御装置
AU629988B2 (en) * 1989-10-11 1992-10-15 Merrell Dow Pharmaceuticals Inc. Inosine/guanosine derivatives as antineoplastic agents
JP2528901Y2 (ja) * 1991-01-17 1997-03-12 住友精密工業株式会社 薄型微小ストロークシリンダ
US5295944A (en) * 1991-05-14 1994-03-22 Dana-Farber Cancer Institute Method for treating a tumor with ionizing radiation
US5302168A (en) * 1991-09-05 1994-04-12 Hess Robert L Method and apparatus for restenosis treatment
WO1993004735A1 (en) * 1991-09-05 1993-03-18 Cedars-Sinai Medical Center Method and apparatus for restenosis treatment
US5750119A (en) * 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5683345A (en) 1994-10-27 1997-11-04 Novoste Corporation Method and apparatus for treating a desired area in the vascular system of a patient
US5899882A (en) * 1994-10-27 1999-05-04 Novoste Corporation Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient
US5679648A (en) * 1994-11-30 1997-10-21 The University Hospital Methods for the treatment and prevention of fungal infections by administration of 3'-deoxypurine nucleosides
DE602005023288D1 (de) * 2004-06-24 2010-10-14 Toyo Suisan Kaisha Sulfopyranosylacylglycerol-Derivate zur Anwendung in Kombination mit Bestrahlung in einer Tumor-Radiotherapie
US9579337B2 (en) * 2011-04-25 2017-02-28 Cornell University Use of uridine and deoxyuridine to treat folate-responsive pathologies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915958A (en) 1972-05-22 1975-10-28 Icn Pharmaceuticals 6-Substituted purine nucleotides
US3919193A (en) 1973-07-06 1975-11-11 Icn Pharmaceuticals 3-Deazaguanosine and derivatives thereof
US4056674A (en) 1973-07-06 1977-11-01 Icn Pharmaceuticals, Inc. Derivatives of 3-deazaguanine
US4141972A (en) 1974-03-29 1979-02-27 Sanraku-Ocean Co., Ltd. Purine nucleoside 5'-phosphate (mono, di or tri) 3'(2')-diphosphates and processes for their preparation
US4056673A (en) 1976-07-16 1977-11-01 Hoffmann-La Roche Inc. Phosphonoacetic acid derivatives of nucleosides
US4177348A (en) 1977-12-13 1979-12-04 United States Government Carbocyclic analogs of cytosine nucleosides
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
GB2037289B (en) 1978-10-31 1983-05-05 Katsunuma N Nucleoside derivatives and an antileukemial agent containing the same as an active ingredient

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU578625B2 (en) * 1983-10-17 1988-11-03 Isis Pharmaceuticals, Inc. Method for inhibiting propagation of virus and anti-viral agent

Also Published As

Publication number Publication date
US4434788A (en) 1984-03-06
EP0045944A1 (en) 1982-02-17
CA1176168A (en) 1984-10-16
JPS5735516A (en) 1982-02-26
EP0045944B1 (en) 1983-08-31
AU7367781A (en) 1982-02-18
JPS634809B2 (enExample) 1988-02-01
DE3160820D1 (en) 1983-10-06

Similar Documents

Publication Publication Date Title
AU574262B2 (en) Substituted 2-phenyl-3-isoxazolidinones
AU542145B2 (en) make
AU544099B2 (en) Triazolylpentenols
AU3629284A (en) 1-hydroxyethyl-azole derivatives and intermediates
AU7367781A (en) Enhancers of anti-tumor effect
AU7390181A (en) Face shield
AU3206284A (en) 2-guanidno-4-heteroarylthiazoles
AU539279B2 (en) Preparation of dialkyldithiophosphinates
DE3168157D1 (en) Enhancer of anti-tumor effect
AU545802B2 (en) Compander
AU545788B2 (en) Compander
AU7086781A (en) Production of interferon ii
AU546641B2 (en) Compander
AU549221B2 (en) Adjustable fastener
AU541143B2 (en) Ethers of substituted hydroxymethylpyrazines
AU535970B2 (en) Perfluoroamides of n-phosphonomethyl-glycinonitrile
AU517843B2 (en) Guanylamidines
AU525004B2 (en) Phthalimidoguanidines
AU546205B2 (en) Preparation of 3-aryl-3-hydroxyphthalimidines
AU548158B2 (en) Photosensor
AU557750B2 (en) Kerving gems
AU4594485A (en) Substituted 1-phenyl-2-triazolyl-pent-1-en-3-ols
AU539735B2 (en) Curtains
AU536918B2 (en) Diamino-platinum compound anti-tumor use
AU533395B2 (en) Adjustable fastener